FDA accepts NDA for Aralez's Yosprala

Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ; TSX:ARZ) said FDA accepted an NDA for Yosprala 325/40 ( PA32540)

Read the full 158 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE